In June 2013, the United States Preventive Services Task Force (USPSTF) released a recommendation for screening of HCV in persons at high risk for infection, and one-time screening for adults born between 1945 and 1965; in consensus with the Centers for Disease Control and Prevention’s (CDC) 2012 recommendations. The recommendations highlight an increasing role for PCPs in HCV prevention, care, and treatment. Additionally, the increased effectiveness and simplicity of treatment regimens for many patients and the growing number of HCV patients are two other significant factors leading to an expanded role for PCPs in managing HCV care.
The program is designed to meet education needs of PCPs (Medical Doctors, Doctors of Osteopathy, Nurse Practitioners, and Physician Assistants), hepatologists, HIV care providers, and allied healthcare professionals (i.e. social workers) who treat and care for patients with HCV.
How is the Program Structured?
The program is structured as an online, self-paced curriculum for providers on the Brainshark web platform. All participants will receive a certificate documenting their completion of this online program from HealthHIV. The curriculum structure and implementation are based on HealthHIV’s existing, successful HIV Primary Care Training & Certificate ProgramTM and LGBT Health Training & Certificate ProgramTM.
The curriculum will be designated as enduring material for continuing medical education (CME) credits, as well as continuing education (CE) credits for pharmacists and allied health professionals for select activities. Participants will be granted between 0.75 and 1.00 credit per activity. Participants will claim only the credit commensurate with the extent of their participation in the educational activity.
The program is based on HealthHIV’s STEP (Staged Training to Engage Providers) Model. The model provides a staged framework for integration of HIV care into primary care. At its core, this dynamic model classifies community health centers and other primary care delivery sites, based upon where they fall in the spectrum of HIV care delivery. The model stages organizational-level of HIV care integration alongside provider HIV care implementation.
There will be five initial modules that must be completed before participants take the final program exam and receive their certificate. The module topics were identified through HealthHCV’s State of Hepatitis C CareTM national survey fielded in Spring 2015 that included a provider educational needs assessment. Below is a list of the proposed modules and their learning objectives:
Module 1: HCV Prevention in Primary Care – Foundations Course
• Describe HCV surveillance data and the implications for individual and public health
• Summarize current recommendations for risk-based and birth cohort screening
• Utilize the most appropriate HCV testing in different clinical settings
• Summarize methods to reduce HCV transmission
Module 2: Trends in HCV Care and Treatment
• Identify new, FDA-approved HCV therapies and describe key implications
• Review considerations in selecting treatment, including assessment of insurance barriers
Module 3: Core Skills for HCV Treatment Management in Primary Care Settings
• Identify appropriate patients and methods in your practice to screen for HCV
• Describe methods to assess patients’ willingness and readiness to begin HCV treatment, and determine when to initiate HCV treatment
• Discuss methods to assess and promote adherence of HCV patients to treatment
• Describe methods for coordination of care between primary care and specialist settings
• Assess patients’ health literacy and health beliefs
• Employ evidence-based techniques to foster open patient-provider communication
• Identify barriers to treatment readiness and adherence and methods to overcome these barriers
• Discuss monitoring HCV patients not on treatment
• Identify indications for the treatment of chronic HCV infection and reasons to consider delaying HCV treatment in patients with HIV/HCV co-infection
• Explain the reported safety and efficacy of currently available treatments for HCV in patients co-infected with HIV
• List HCV/HIV drug combinations to avoid based on potential for drug-drug interactions
• Select guidelines-recommended monitoring for patients being treated for HCV/HIV coinfection.
• Best practices for addressing treatment access barriers and payer restrictions • Strengthening collaborative HCV care management to improve patient linkage and retention in care; maximizing billing and reimbursement for HCV prevention, care and treatment; and • Innovations in HCV research.For more information, please contact Marissa Tonelli at [email protected].